No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

PURPLESUN Battles the Invisible Enemy – COVID-19 – There is Light

Company in Partnership with Hackensack Meridian Health and Northwell Health Form a Private Sector Partnership to Provide FMUV Shadowless Delivery Light Decontamination Technology to Government Agencies

Editor: What To Know

  • The trio collaborated to provide access to PurpleSun technology to government agencies in order to help protect the crew and pilots to maximize operational readiness of their no-fail mission criteria.
  • Having purchased multiple devices, we were able and proud to extend the technology to the government to protect their pilots and crew during this time of crisis,” said Derek Anderson, Executive Director of Northern Westchester Hospital.
  • is a technology company on a mission to transform healthcare and provide a sustainable impact for the healthiest environments.

September 23, 2020

PURPLESUN Inc. is a technology company on a mission to transform healthcare and provide a sustainable impact for the healthiest environments. Amid the COVID-19 crisis, there is light.

PurpleSun designs and manufactures hospital-grade mechatronic systems that are user friendly and provide a special type of Focused Multivector Ultraviolet (FMUV) light technology, for the purpose of disinfection in 90 seconds.

The company uses proprietary FMUV – focused light energy to improve germicidal effectiveness and speed – to quickly kill off organisms, as proven by several top publications, including the American Journal of Infection Control.

After extensive electrical and ultraviolet light emission testing, including risk mitigation analysis, the PurpleSun E300 was certified to the Standard, IEC 61010-1, by Underwriters Laboratory. The E300 modular and mobile PurpleSun system can be used to treat equipment and rooms while people continue to work around the system safely.

With a community of innovative minds from top executives, clinicians and board members at Hackensack Meridian Health, Northwell Health, and PurpleSun — the trio collaborated to provide access to PurpleSun technology to government agencies in order to help protect the crew and pilots to maximize operational readiness of their no-fail mission criteria.

At Hackensack Meridian Health, a leading not-for-profit health care organization that is the most comprehensive and truly integrated health care network in New Jersey. “We’re proud to help our crew members protect against the common enemy, COVID-19,” said Robert C. Garrett, CEO of Hackensack Meridian Health. “PurpleSun was one of the first investments made through our innovative Bear’s Den incubator program. Now that we’re in the thick of this pandemic, the choice of such an innovative disinfection technology seems more prescient than ever.”

At Northwell Health is New York State’s largest health care provider. “PurpleSun has played an important role in our fight against COVID-19. When the call came to support this initiative, the team stepped up to make the partnership happen – yet another testament to the culture at Northern Westchester Hospital and Northwell Health. Northern Westchester Hospital, along with Staten Island University Hospital and Cohen Children’s Medical Center were the first hospitals to purchase and use PurpleSun in our efforts to enhance disinfection. Having purchased multiple devices, we were able and proud to extend the technology to the government to protect their pilots and crew during this time of crisis,” said Derek Anderson, Executive Director of Northern Westchester Hospital.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy